Pfizer halts third study of experimental pain drug

Pfizer halts third study of experimental pain drug
(AP:NEW YORK) Drugmaker Pfizer Inc. is stopping tests of an experimental drug for two types of pain at the request of federal regulators. Pfizer was testing tanezumab in patients with chronic low back pain and with painful nerve damage from diabetes complications.
Read more on INO News

Pfizer Suspends Chronic Pain Studies in Tanezumab Clinical Trial Program; Some Studies Continue in Areas of Unmet …
Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration , the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab.
Read more on PR Newswire via Yahoo! Finance

 Mail this post

Tags: Drug - experimental - halts - Pain - Pfizer - Study - Third